SAN ANTONIO – A new study from UT Health San Antonio has provided new insights into Alzheimer’s disease. Researchers have uncovered a genetic factor that may contribute to the risk of late onset of ...
Many people use the terms Alzheimer’s disease and dementia as if they mean the same thing, but they actually refer to ...
The Global Alzheimer’s Platform Foundation® (GAP) is pleased to announce a collaboration with the Biomarkers of Aging Consortium, a consortium dedicated to the developing and validating biomarkers for ...
Two new PET radiotracers have outperformed the only currently Food and Drug Administration (FDA) approved radiotracer for ...
(HealthDay News) — Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the Alzheimer’s Association and the Society for Nuclear Medicine ...
Scientists have developed two new imaging agents that work better than the only currently approved one for detecting tau ...
The Global Alzheimer’s Platform Foundation® (GAP) is pleased to announce a collaboration with the Biomarkers of Aging Consortium, a consortium dedicated to the developing and validating biomarkers for ...
Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for ...
Research indicates longer REM latency is associated with higher Alzheimer's biomarkers, pointing to its potential as an early ...
Lantheus strengthens its radiopharmaceutical business with Evergreen and Life Molecular acquisitions, adding oncology and ...
Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...